As of Feb 05
| -0.23 / -1.63%|
The 8 analysts offering 12-month price forecasts for Astellas Pharma Inc have a median target of 21.68, with a high estimate of 25.35 and a low estimate of 17.55. The median estimate represents a +56.44% increase from the last price of 13.86.
The current consensus among 8 polled investment analysts is to Buy stock in Astellas Pharma Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.